Amy Weeks
Gerontology · Gainesville, GANPI 1225771595
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $894, more than ten times the $13 reported in 2023.
Across 70 payments — averaging $23.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$368
- Convatec Inc.$137
- Myriad Genetic Laboratories, Inc.$102
- Ferring Pharmaceuticals Inc.$100
- AbbVie$97
- Urogen Pharma, Inc.$81
- plus $764 from 22 others
What the payments were for
- Food & beverage$1,649100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $368 |
| Convatec Inc. | 4 | $137 |
| Myriad Genetic Laboratories, Inc. | 5 | $102 |
| Ferring Pharmaceuticals Inc. | 5 | $100 |
| AbbVie | 4 | $97 |
| Urogen Pharma, Inc. | 3 | $81 |
| Astellas Pharma US Inc | 3 | $74 |
| Axonics, Inc. | 2 | $64 |
| Dendreon Pharmaceuticals LLC | 3 | $57 |
| Tempus AI, Inc | 2 | $56 |
| Merck | 2 | $54 |
| Medtronic | 1 | $49 |
| Boston Scientific | 2 | $43 |
| Bayer | 2 | $43 |
| Procept Biorobotics Corporation | 1 | $38 |
| Blue Earth Diagnostics | 1 | $37 |
| Vertex | 1 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $29 |
| Endo USA, Inc. | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Agiliti Surgical, Inc. | 1 | $22 |
| Laborie Medical Technologies Corp. | 2 | $22 |
| Accord Healthcare, Inc. | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| Aurinia Pharma U.S., Inc. | 1 | $13 |
How this compares
$1,649 in reported general payments places this provider in the 70th percentile of 197 gerontology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 20 | $16,167 |
| GemtesaVibegron | 18 | $12,309 |
| Tamsulosin Hcl | 191 | $2,520 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 97 | $1,267 |
| Finasteride | 80 | $1,195 |
| Methenamine Hippurate | 17 | $1,013 |
| Estradiol | 14 | $855 |
| Bethanechol Chloride | 28 | $677 |
| Cefdinir | 62 | $670 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $428 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $408 |
| Cephalexin | 16 | $301 |
| Doxycycline Hyclate | 24 | $229 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $184 |
| Oxybutynin Chloride | 20 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $74 | $16,16720 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $368 | $12,30918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 197 gerontology providers in Georgia.
Other gerontology in Gainesville
- Jennifer WaiteGainesville$5K
- Rachel LeboloGainesville$3K
- Jennifer SargentGainesville$2K
- Anna KomotoGainesville$2K
- Kayla RyleeGainesville$2K
- Michelle DavisGainesville$2K
- Rebecca SimpsonGainesville$2K
- Chance PerryGainesville$2K
- Carolyn ClevengerAtlanta$65K
- Mitzi LewisAtlanta$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.